Showing results (141-150 of 157) with videos related to
Sort By:
Pageof 16
Journal of Chemical Neuroanatomy|November 13, 2016
Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brainRachel A Cliburn, Amy R Dunn, Kristen A Stout, et al.Biomedicines|January 23, 2024
Accelerated Brain Atrophy, Microstructural Decline and Connectopathy in Age-Related Macular DegenerationJacques A Stout, Ali Mahzarnia, Rui Dai, et al.The Journal of Pharmacology and Experimental Therapeutics|September 23, 2015
Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic DeficitsPaula L Vieira-Brock, Lisa M McFadden, Shannon M Nielsen, et al.Proceedings of the National Academy of Sciences of the United States of America|March 2, 2017
Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson diseaseAmy R Dunn, Kristen A Stout, Minagi Ozawa, et al.Nature Neuroscience|January 9, 2020
Author Correction: Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chainSteven M Graves, Zhong Xie, Kristen A Stout, et al.American Journal of Respiratory Cell and Molecular Biology|November 25, 2003
Expression of interleukin-5- and granulocyte macrophage-colony-stimulating factor-responsive genes in blood and airway eosinophilsMary E Bates, Lin Ying Liu, Stephane Esnault, et al.Nature Neuroscience|December 18, 2019
Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chainSteven M Graves, Zhong Xie, Kristen A Stout, et al.Experimental Neurology|January 5, 2013
Exposure to the polybrominated diphenyl ether mixture DE-71 damages the nigrostriatal dopamine system: role of dopamine handling in neurotoxicityJoshua M Bradner, Tiffany A Suragh, W Wyatt Wilson, et al.Nature|November 4, 2021
Disruption of mitochondrial complex I induces progressive parkinsonismPatricia González-Rodríguez, Enrico Zampese, Kristen A Stout, et al.The Journal of Pharmacology and Experimental Therapeutics|October 29, 2011
Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposureLisa M McFadden, Greg C Hadlock, Scott C Allen, et al.Pageof 16